AgomAb Therapeutics NV ADR(AGMB)
$6.990.00 (0.00%)
AGMB
AgomAb Therapeutics NV ADR stock forecast
$6.99
At close:0.00 (0.00%)
AgomAb Therapeutics NV ADR (AGMB) Stock Forecast & Price Target
41 Followers
AGMB Analyst Ratings
Strong Buy
6Buy0Hold0Sell
Based on 6 analysts giving stock ratings to AgomAb Therapeutics NV ADR in the past 3 months
AGMB Stock 12 Month Forecast
Average Price Target
$35.20▲(403.58% Upside)Based on 6 Wall Street analysts offering 12 month price targets for AgomAb Therapeutics NV ADR in the last 3 months. The average price target is $35.20 with a high forecast of $60.00 and a low forecast of $17.00. The average price target represents a 403.58% change from the last price of $6.99.
Past 12 Months12 Month ForecastJan2026Oct2026
High$60.00
Average$35.20
Low$17.00
Highest Price TargetHighest$60.00Average Price Target$35.20Lowest Price TargetLowest$17.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Michael Ulz | Morgan Stanley | $28 | buy | 300.57%Upside | Assigned | 11/02/26 | ||
| Patrick Trucchio | H.C. Wainwright | $35 | buy | 400.72%Upside | Reiterated | 10/20/26 | ||
| Yasmeen Rahimi | Piper Sandler | $60 | buy | 758.37%Upside | Reiterated | 10/14/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | $36 | buy | 415.02%Upside | Reiterated | 10/02/26 | ||
| Anupam Rama | J.P. Morgan | ― | buy | ― | Reiterated | 09/14/26 | ||
| Yanni Souroutzidis | Cantor Fitzgerald | $13→$17 | buy | 143.20%Upside | Initiated | 08/19/26 | ||
| William Wood | B. Riley Securities | $34 | buy | 386.41%Upside | Initiated | 07/23/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Michael UlzMorgan Stanley | BuyAssigned$28 | 11/02/26 | 300.57%Upside | ||
| Patrick TrucchioH.C. Wainwright | BuyReiterated$35 | 10/20/26 | 400.72%Upside | ||
| Yasmeen RahimiPiper Sandler | BuyReiterated$60 | 10/14/26 | 758.37%Upside | ||
| Unknown AnalystLeerink PartnersNot Ranked | BuyReiterated$36 | 10/02/26 | 415.02%Upside | ||
| Anupam RamaJ.P. Morgan | BuyReiterated | 09/14/26 | ― | ||
| Yanni SouroutzidisCantor Fitzgerald | BuyInitiated$13→$17 | 08/19/26 | 143.20%Upside | ||
| William WoodB. Riley Securities | BuyInitiated$34 | 07/23/26 | 386.41%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering AgomAb Therapeutics NV ADR
3 Months
Success Rate0/5 ratings generated profit
0%
Average Return
-21.80%
Copying Patrick Trucchio's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -21.80% per trade.
1 Year
Success Rate0/5 ratings generated profit
0%
Average Return
-31.12%
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -31.12% per trade.
2 Years
Success Rate0/5 ratings generated profit
0%
Average Return
-31.12%
Copying Patrick Trucchio's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -31.12% per trade.
AGMB Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 10 | 15 | 22 | 16 |
| Buy | 1 | 1 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 4 | 11 | 17 | 24 | 17 |
In the current month, AGMB has received 17 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AGMB average Analyst price target in the past 3 months is 35.20.
AGMB Financial Forecast
AGMB Stock Forecast FAQ
What is AGMB’s average 12-month price target, according to analysts?
Based on analyst ratings, AgomAb Therapeutics NV ADR’s 12-month average price target is $35.20.
What is AGMB’s upside potential, based on the analysts’ average price target?
AgomAb Therapeutics NV ADR has 403.58% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AGMB a Buy, Sell or Hold?
AgomAb Therapeutics NV ADR has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
What is AgomAb Therapeutics NV ADR’s price target?
The average price target for AgomAb Therapeutics NV ADR is $35.20. This is based on 6 12-month price targets, issued in the past 3 months. The highest analyst price target is $60.00, the lowest forecast is $17.00. The average price target represents a 403.58% increase from the current price of $6.99.
What do analysts say about AgomAb Therapeutics NV ADR?
AgomAb Therapeutics NV ADR’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Street analysts.
How can I buy shares of AGMB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
